Business LineBusiness Line

Broker’s call: Ashok Leyland (Hold)

Bacaan kurang dari 1 minit

Target: ₹162

CMP: ₹167.80

Ashok Leyland (AL) reported an in-line 2QFY27 performance, with revenue growing 39.4 per cent y-o-y to ₹13,364 crore, exceeding estimates by 2.9 per cent, however, a 373 bps y-o-y contraction in gross margin offset the benefits of operating leverage, limiting EBITDA growth to 16.2 per cent to ₹1,350 crore (vs est of ₹1,340 crore) while EBITDA margin declined 202 bps to 10.1 % (vs. 10.3% estimated) and adjusted PAT grew 7.1 per cent to ₹870 crore (vs est of ₹900 crore).

The company’s domestic MHCV outperformance, traction in preimmunised products and expanding LCV presence indicate strengthening competitive positioning. Management’s expectation of mid-teen CV industry growth in FY27, supported by replacement demand, infrastructure activity and improving fleet economics, provides a favourable demand outlook.

While AL’s strong domestic market position and expanding non-core businesses provide structural support to its medium-term growth outlook, we believe the near-term risk-reward remains balanced, with margin pressures limiting earnings upside. A meaningful moderation in raw material costs remains the key potential earnings upgrade trigger, offering scope for a stronger-than-expected margin recovery and an improved earnings trajectory.

Following Q2-FY27 results, we have cut our FY27E/FY28E earnings estimates by 12.1/3.9 per cent, respectively, and retain our Hold rating with an unchanged SOTP-based target price of ₹162, valuing the standalone business at 12.5x FY28E EV/EBITDA and assigning ₹15/share to strategic investments.

Baca artikel penuh
Dapatkan akses tanpa had kepada artikel dari Business Line dan semua sumber berita di TradingView.